Experience

    • The lead investor in an approximately $120 million continuation fund, sponsored by a leading Israeli private equity sponsor, to acquire multiple assets from an end of term fund.
    • Ozon in its $750 million offering of 1.875% senior bonds due 2026 convertible into American depositary shares representing ordinary shares of Ozon.
    • A consortium of international secondaries fund sponsors led by Pantheon and Aberdeen Standard in a fund recapitalization involving the single-asset transfer of KD Pharma Group, a German vitamin supplement manufacturer, and related investment transaction.

Education

  • University of Cambridge, 2016, B.A.